During the past decade, Queen Mary Hospital; Dept. of Clinical Oncology conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Mary Hospital; Dept. of Clinical Oncology" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "The University of Hong Kong" with 8 trials sponsored, "Hong Kong Nasopharyngeal Cancer Study Group Limited" with 2 trials sponsored, "CCTU" with 1 trials sponsored and "Chinese University of Hong Kong" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital; Dept. of Clinical Oncology" #1 collaborator was "Chinese University of Hong Kong" with 1 trials as a collaborator, "Hong Kong Nasopharyngeal Cancer Study Group Limited" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital; Dept. of Clinical Oncology" are "Nasopharyngeal Carcinoma" (5 trials), "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials) and "Chemo-brain" (1 trials). Many other conditions were trialed in "Queen Mary Hospital; Dept. of Clinical Oncology" in a lesser frequency.

Most popular intervention types in "Queen Mary Hospital; Dept. of Clinical Oncology" are "Drug" (17 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Cisplatin" (4 trials), "Alectinib" (3 trials), "Durvalumab" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Mary Hospital; Dept. of Clinical Oncology" are 20 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Queen Mary Hospital; Dept. of Clinical Oncology". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Queen Mary Hospital; Dept. of Clinical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Mary Hospital; Dept. of Clinical Oncology, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".